Real-world 10-year experiences with intravitreal treatment with ranibizumab and aflibercept for neovascular age-related macular degeneration - Resultat

Real-world 10-year experiences with intravitreal treatment with ranibizumab and aflibercept for neovascular age-related macular degeneration

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Dokumenter

Real-world 10-year experiences with intravitreal treatment with ranibizumab and aflibercept for neovascular age-related macular degeneration_(accepted_version)
Accepteret manuskript, 289 KB, PDF-dokument

Troels Brynskov
Inger Christine Munch
Tobias Larsen
Liv Erngaard
Sørensen, Torben Lykke

Originalsprog	Engelsk
Tidsskrift	Acta Ophthalmologica
Vol/bind	98
Udgave nummer	2
Sider (fra-til)	132-138
ISSN	1755-375X
DOI	https://doi.org/10.1111/aos.14183
Status	Udgivet - 2020

ID: 222095444